Trials / Terminated
TerminatedNCT00000310
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Serotonin/Dopamine Antagonism of Cocaine Effect
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
Detailed description
Risperidone in low doses is compared with placebo in a 6-week randomized trial. Subjects also receive supportive counseling. Outcome measure include rating of behavior, mood, drug abuse, global function, and urine toxicology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risperidone |
Timeline
- Start date
- 1996-01-01
- Primary completion
- 1996-03-01
- Completion
- 1996-03-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000310. Inclusion in this directory is not an endorsement.